{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T01:24:01Z","timestamp":1648776241221},"reference-count":66,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","neurologic.theclinics.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurologic Clinics"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.ncl.2016.04.005","type":"journal-article","created":{"date-parts":[[2016,7,19]],"date-time":"2016-07-19T16:31:06Z","timestamp":1468945866000},"page":"611-629","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Neuro-Ophthalmology Cases for the Neurologist"],"prefix":"10.1016","volume":"34","author":[{"given":"Stacy V.","family":"Smith","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alec L.","family":"Amram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elsa M.","family":"Rodarte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew G.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ncl.2016.04.005_bib1","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1056\/NEJMra022694","article-title":"Medium- and large-vessel vasculitis","volume":"349","author":"Weyand","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ncl.2016.04.005_bib2","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.jocn.2009.05.002","article-title":"Giant cell arteritis","volume":"16","author":"Chew","year":"2009","journal-title":"J\u00a0Clin Neurosci"},{"key":"10.1016\/j.ncl.2016.04.005_bib3","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1007\/s10067-006-0493-x","article-title":"Oral and ocular\/orbital manifestations of temporal arteritis: a disease with deceptive clinical symptoms and devastating consequences","volume":"26","author":"Paraskevas","year":"2007","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.ncl.2016.04.005_bib4","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1001\/jama.287.22.2996","article-title":"Temporal arteritis: a cough, toothache, and tongue infarction","volume":"287","author":"Hellmann","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.ncl.2016.04.005_bib5","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1001\/jama.287.1.92","article-title":"Does this patient have temporal arteritis?","volume":"287","author":"Shmerling","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.ncl.2016.04.005_bib6","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1002\/art.1780310607","article-title":"Trends in incidence and clinical presentation of temporal arteritis in Olmsted County, Minnesota, 1950-1985","volume":"31","author":"Machado","year":"1988","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ncl.2016.04.005_bib7","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1159\/000070631","article-title":"Management of giant cell arteritis. Our 27-year clinical study: new light on old controversies","volume":"217","author":"Hayreh","year":"2003","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.ncl.2016.04.005_bib8","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.1002\/art.22163","article-title":"Treatment of giant cell arteritis using induction therapy with high-dose glucocorticoids: a double-blind, placebo-controlled, randomized prospective clinical trial","volume":"54","author":"Mazlumzadeh","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ncl.2016.04.005_bib9","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3109\/01658107.2014.883635","article-title":"Biologic therapy for the treatment of giant cell arteritis","volume":"38","author":"Ostrowski","year":"2014","journal-title":"Neuroophthalmol"},{"key":"10.1016\/j.ncl.2016.04.005_bib10","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.ophtha.2005.01.036","article-title":"Poor prognosis of visual outcome after visual loss from giant cell arteritis","volume":"112","author":"Danesh-Meyer","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ncl.2016.04.005_bib11","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1034\/j.1600-0420.2002.800403.x","article-title":"Visual improvement with corticosteroid therapy in giant cell arteritis. Report of a large study and review of literature","volume":"80","author":"Hayreh","year":"2002","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1016\/j.ncl.2016.04.005_bib12","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/S0161-6420(94)31102-X","article-title":"Visual morbidity in giant cell arteritis. Clinical characteristics and prognosis for vision","volume":"101","author":"Liu","year":"1994","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ncl.2016.04.005_bib13","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s10067-010-1616-y","article-title":"Delays in recognition and management of giant cell arteritis: results from a retrospective audit","volume":"30","author":"Ezeonyeji","year":"2011","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.ncl.2016.04.005_bib14","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1093\/rheumatology\/36.2.251","article-title":"Clinical features in patients with permanent visual loss due to biopsy-proven giant cell arteritis","volume":"36","author":"Font","year":"1997","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.ncl.2016.04.005_bib15","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1016\/j.diabres.2010.09.038","article-title":"Hyperglycemic hyperosmolar state and rhino-orbital mucormycosis","volume":"91","author":"Pinto","year":"2011","journal-title":"Diabetes Res Clin Pract"},{"issue":"2","key":"10.1016\/j.ncl.2016.04.005_bib16","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jiph.2012.01.003","article-title":"Cerebro-rhino orbital mucormycosis: an update","volume":"5","author":"Wali","year":"2012","journal-title":"J\u00a0Infect Public Health"},{"key":"10.1016\/j.ncl.2016.04.005_bib17","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s11908-010-0129-9","article-title":"Recent advances in the treatment of mucormycosis","volume":"12","author":"Spellberg","year":"2010","journal-title":"Curr Infect Dis Rep"},{"key":"10.1016\/j.ncl.2016.04.005_bib18","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/1469-0691.12371","article-title":"ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013","volume":"20","author":"Cornely","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ncl.2016.04.005_bib19","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1086\/590004","article-title":"Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis","volume":"47","author":"Chamilos","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ncl.2016.04.005_bib20","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1086\/432579","article-title":"Epidemiology and outcome of zygomycosis: a review of 929 reported cases","volume":"41","author":"Roden","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ncl.2016.04.005_bib21","doi-asserted-by":"crossref","first-page":"e533","DOI":"10.1016\/j.ijid.2011.02.005","article-title":"Mucormycosis in immunocompetent patients: a case-series of patients with maxillary sinus involvement and a critical review of the literature","volume":"15","author":"Mignogna","year":"2011","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ncl.2016.04.005_bib22","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1128\/CMR.18.3.556-569.2005","article-title":"Novel perspectives on mucormycosis: pathophysiology, presentation, and management","volume":"18","author":"Spellberg","year":"2005","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ncl.2016.04.005_bib23","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1172\/JCI32338","article-title":"The iron chelator deferasirox protects mice from mucormycosis through iron starvation","volume":"117","author":"Ibrahim","year":"2007","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.ncl.2016.04.005_bib24","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1086\/428780","article-title":"Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case\u2013control observational study of 27 recent cases","volume":"191","author":"Kontoyiannis","year":"2005","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.ncl.2016.04.005_bib25","first-page":"364","article-title":"Host defense in diabetes mellitus: the feckless phagocyte during poor control and ketoacidosis","volume":"19","author":"Bagdade","year":"1970","journal-title":"Diabetes"},{"key":"10.1016\/j.ncl.2016.04.005_bib26","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1093\/clinids\/10.3.551","article-title":"Adjunctive hyperbaric oxygen for treatment of rhinocerebral mucormycosis","volume":"10","author":"Ferguson","year":"1988","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.ncl.2016.04.005_bib27","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2337\/diacare.31.12.1109","article-title":"A\u00a0mechanism of susceptibility to mucormycosis in diabetic ketoacidosis: transferring and iron availability","volume":"31","author":"Artis","year":"1982","journal-title":"Diabetes"},{"key":"10.1016\/j.ncl.2016.04.005_bib28","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1016\/S0140-6736(03)14904-5","article-title":"Glucocorticoids and invasive fungal infections","volume":"362","author":"Lionakis","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ncl.2016.04.005_bib29","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1288\/00005537-198004000-00010","article-title":"Patient survival factors in paranasal sinus mucormycosis","volume":"90","author":"Blitzer","year":"1980","journal-title":"Laryngoscope"},{"key":"10.1016\/j.ncl.2016.04.005_bib30","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1288\/00005537-198408000-00013","article-title":"Twenty five years\u2019 experience treating cerebro-rhino-orbital mucormycosis","volume":"94","author":"Abedi","year":"1984","journal-title":"Laryngoscope"},{"key":"10.1016\/j.ncl.2016.04.005_bib31","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1086\/605445","article-title":"Zygomycosis in solid organ transplant recipients: a prospective, matched case\u2013control study to assess risks for disease and outcome","volume":"200","author":"Singh","year":"2009","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.ncl.2016.04.005_bib32","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1086\/500212","article-title":"Posaconazole is effective as salvage therapy in zygomycosis: a retrospective summary of 91 cases","volume":"42","author":"Ivan Burik","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ncl.2016.04.005_bib33","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1128\/AAC.50.1.126-133.2006","article-title":"Posaconazole as salvage therapy for zygomycosis","volume":"50","author":"Greenberg","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ncl.2016.04.005_bib34","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1056\/NEJMoa061094","article-title":"Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia","volume":"356","author":"Cornely","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ncl.2016.04.005_bib35","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1056\/NEJMoa061098","article-title":"Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease","volume":"356","author":"Ullmann","year":"2007","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.ncl.2016.04.005_bib36","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"The hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.ncl.2016.04.005_bib37","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.3171\/2014.8.JNS132139","article-title":"Co-prevalence of other tumors in patients harboring pituitary tumors","volume":"121","author":"Couldwell","year":"2014","journal-title":"J\u00a0Neurosurg"},{"issue":"1","key":"10.1016\/j.ncl.2016.04.005_bib38","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s11102-010-0253-4","article-title":"Demographic differences in incidence for pituitary adenoma","volume":"14","author":"McDowell","year":"2011","journal-title":"Pituitary"},{"issue":"4","key":"10.1016\/j.ncl.2016.04.005_bib39","doi-asserted-by":"crossref","first-page":"e0125639","DOI":"10.1371\/journal.pone.0125639","article-title":"Increased short-term beat-to-beat variability of QT interval in patients with acromegaly","volume":"10","author":"Orosz","year":"2015","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.ncl.2016.04.005_bib40","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/BF02738730","article-title":"Incidence, pathology, and recurrence of pituitary adenomas: study of 647 unselected surgical cases","volume":"6","author":"Terada","year":"1995","journal-title":"Endocr Pathol"},{"issue":"2","key":"10.1016\/j.ncl.2016.04.005_bib41","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s10143-014-0525-y","article-title":"Invasive adenoma and pituitary carcinoma: a SEER database analysis","volume":"37","author":"Hansen","year":"2014","journal-title":"Neurosurg Rev"},{"issue":"3","key":"10.1016\/j.ncl.2016.04.005_bib42","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s11060-014-1386-5","article-title":"The pituitary stalk effect: is it a passing phenomenon?","volume":"117","author":"Bergsneider","year":"2014","journal-title":"J\u00a0Neurooncol"},{"issue":"3","key":"10.1016\/j.ncl.2016.04.005_bib43","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ando.2015.04.006","article-title":"Neuro-ophthalmologic exploration in non-functioning pituitary adenoma","volume":"76","author":"Abouaf","year":"2015","journal-title":"Ann Endocrinol (Paris)"},{"issue":"2","key":"10.1016\/j.ncl.2016.04.005_bib44","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00401-007-0243-4","article-title":"The 2007 WHO classification of tumours of the central nervous system","volume":"114","author":"Louis","year":"2007","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.ncl.2016.04.005_bib45","first-page":"3","article-title":"The netter collection of medical illustrations","volume":"vol. 2","author":"Young","year":"2011"},{"key":"10.1016\/j.ncl.2016.04.005_bib46","first-page":"241","article-title":"Diagnosis and treatment of pituitary adenomas","volume":"4","author":"Chanson","year":"2004","journal-title":"Minerva Endocrinol"},{"issue":"4","key":"10.1016\/j.ncl.2016.04.005_bib47","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nrc1320","article-title":"Molecular targets in pituitary tumours","volume":"4","author":"Heaney","year":"2004","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"10.1016\/j.ncl.2016.04.005_bib48","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s11060-014-1426-1","article-title":"Editorial: pituitary tumors","volume":"117","author":"Bergsneider","year":"2014","journal-title":"J\u00a0Neurooncol"},{"issue":"3","key":"10.1016\/j.ncl.2016.04.005_bib49","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1055\/s-2007-979681","article-title":"Third nerve palsies","volume":"27","author":"Bruce","year":"2007","journal-title":"Semin Neurol"},{"issue":"6","key":"10.1016\/j.ncl.2016.04.005_bib50","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1001\/archopht.116.6.723","article-title":"Pupil involvement in patients with diabetes associated oculomotor nerve palsy","volume":"116","author":"Jacobson","year":"1998","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"10.1016\/j.ncl.2016.04.005_bib51","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0039-6257(01)00303-4","article-title":"The evaluation of isolated third nerve palsy revisited: an update on the evolving role of magnetic resonance, computed tomography, and catheter angiography","volume":"47","author":"Lee","year":"2002","journal-title":"Surv Ophthalmol"},{"issue":"2","key":"10.1016\/j.ncl.2016.04.005_bib52","doi-asserted-by":"crossref","first-page":"63","DOI":"10.5469\/neuroint.2014.9.2.63","article-title":"Clinical practice guideline for the management of intracranial aneurysms","volume":"9","author":"Jeong","year":"2014","journal-title":"Neurointervention"},{"issue":"1","key":"10.1016\/j.ncl.2016.04.005_bib53","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S0002-9394(99)00107-5","article-title":"The emerging role of magnetic resonance angiography in the management of patients with third cranial nerve palsy","volume":"128","author":"Jacobson","year":"1999","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ncl.2016.04.005_bib54","doi-asserted-by":"crossref","first-page":"175","DOI":"10.4103\/2152-7806.170029","article-title":"Detection of unruptured intracranial aneurysms on noninvasive imaging. Is there still a role for digital subtraction angiography?","volume":"6","author":"Rustemi","year":"2015","journal-title":"Surg Neurol Int"},{"issue":"3","key":"10.1016\/j.ncl.2016.04.005_bib55","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1001\/archophthalmol.2011.25","article-title":"Neuroimaging and acute ocular motor mononeuropathies: a prospective study","volume":"129","author":"Murchison","year":"2011","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"10.1016\/j.ncl.2016.04.005_bib56","first-page":"21","article-title":"Evolution of oculomotor nerve palsies","volume":"12","author":"Capo","year":"1992","journal-title":"J\u00a0Clin Neuroophthalmol"},{"issue":"9","key":"10.1016\/j.ncl.2016.04.005_bib57","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.clineuro.2012.03.016","article-title":"Recovery of posterior communicating artery aneurysm-induced oculomotor nerve paresis after endovascular treatment","volume":"114","author":"Gu","year":"2012","journal-title":"Clin Neurol Neurosurg"},{"issue":"9","key":"10.1016\/j.ncl.2016.04.005_bib58","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1001\/archopht.1987.01060090063028","article-title":"The safety and efficacy of topical 1% ALO 2145 (p-aminoclonidine hydrochloride) in normal volunteers","volume":"105","author":"Abrams","year":"1987","journal-title":"Arch Ophthalmol"},{"issue":"7","key":"10.1016\/j.ncl.2016.04.005_bib59","first-page":"506","article-title":"Apraclonidine in the diagnosis of Horner's syndrome","volume":"97","author":"Moodley","year":"2007","journal-title":"S\u00a0Afr Med J"},{"issue":"11","key":"10.1016\/j.ncl.2016.04.005_bib60","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1136\/bjo.2005.074492","article-title":"The sensitivity and specificity of 0.5% apraclonidine in the diagnosis of oculosympathetic paresis","volume":"89","author":"Koc","year":"2005","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"10.1016\/j.ncl.2016.04.005_bib61","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/CRD.0b013e318247cd15","article-title":"Cervical carotid artery dissection: current review of diagnosis and treatment","volume":"20","author":"Patel","year":"2012","journal-title":"Cardiol Rev"},{"issue":"10","key":"10.1016\/j.ncl.2016.04.005_bib62","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1212\/01.wnl.0000244486.30455.71","article-title":"Incidence and outcome of cervical artery dissection: a population-based study","volume":"67","author":"Lee","year":"2006","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.ncl.2016.04.005_bib63","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1212\/WNL.45.8.1517","article-title":"Headache and neck pain in spontaneous internal carotid and vertebral artery dissections","volume":"45","author":"Silbert","year":"1995","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.ncl.2016.04.005_bib64","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S1474-4422(15)70018-9","article-title":"Antiplatelet treatment compared with anticoagulation treatment for cervical artery dissection (CADISS): a randomised trial","volume":"14","author":"Markus","year":"2015","journal-title":"Lancet Neurol"},{"issue":"1","key":"10.1016\/j.ncl.2016.04.005_bib65","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/WCO.0b013e328320d2b2","article-title":"The diagnosis and management of supraaortic arterial dissections","volume":"22","author":"Goyal","year":"2009","journal-title":"Curr Opin Neurol"},{"issue":"2","key":"10.1016\/j.ncl.2016.04.005_bib66","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00234-002-0838-3","article-title":"Extracranial internal carotid and vertebral artery dissections: angiographic spectrum, course and prognosis","volume":"45","author":"Pelkonen","year":"2003","journal-title":"Neuroradiology"}],"container-title":["Neurologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733861916300056?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733861916300056?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T11:50:48Z","timestamp":1536580248000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733861916300056"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":66,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["S0733861916300056"],"URL":"https:\/\/doi.org\/10.1016\/j.ncl.2016.04.005","relation":{},"ISSN":["0733-8619"],"issn-type":[{"value":"0733-8619","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuro-Ophthalmology Cases for the Neurologist","name":"articletitle","label":"Article Title"},{"value":"Neurologic Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ncl.2016.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}